Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Park, Richard
NCT05658575 / 2019-002717-19: Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Recruiting	2/3	300	Europe, US, RoW	Dapansutrile, OLT1177, Placebo Tablet	Olatec Therapeutics LLC, Olatec Therapeutics LLC	Acute Gout Flare, Gout Attack, Gout Flare, Gouty Arthritis, Gout, Arthritis, Joint Pain	09/25	10/25
NCT06240455: Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz	Suspended	2	176	US	WP1302, WP1302 placebo, methimazole	Worg Biotherapeutics Inc.	Graves Disease	05/26	08/26
TRANSFORM, NCT06112418: A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	Recruiting	N/A	7500	US	The Cleerly CAD Staging System	Cleerly, Inc., CPC Clinical Research	Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome	03/29	03/29